IP Library Granted Patent US 8,771,265
Granted Patent B2
US 8,771,265 · App. 12/797,453 · Granted Jul 8, 2014

Polymer composites for biomedical applications and methods of making

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,265
App. No.
12/797,453
Granted
Jul 8, 2014
Kind
B2
Abstract

A biomedical polymer composite that exhibits ultra-low thermal conductivity properties. In a preferred embodiment, the biomedical polymer composite comprises a base polymer component with a dispersed thermally non-conductive filler component consisting of glass or ceramic nanospheres or microspheres that have a thermal conductivity of less than 5 W/m-K, and preferably less than 2 W/m-K. In one embodiment, the polymer composite has an electrically conductive filler and can be used in a filament for treating arteriovascular malformations. In another embodiment, the polymeric composite can be used as an energy-coupling means to apply energy to tissue.

Claims (15)

1. A method of thermally treating tissue in a body, comprising:

selecting a targeted portion of a tissue structure to be ablated using transmitted energy;

identifying a nearby insulation portion of tissue to be insulated from the transmitted energy;

introducing a flowable material into a delivery lumen of an elongate introducer, such that the flowable material flows through the delivery lumen, exits out a distal opening of the elongate introducer, and is deposited onto the insulation portion of tissue, thereby forming an insulative layer on the insulation portion of tissue;

electrically coupling a radiofrequency (RF) energy source to a conductive liquid or gel electrode contacting the targeted portion of the tissue structure;

transmitting RF energy from the RF energy source to the targeted portion of the tissue structure via the conductive liquid or gel electrode to thereby treat at least a portion of the targeted portion of the tissue structure.

2. The method of claim 1 , wherein introducing the flowable material comprises extruding the flowable material through the delivery lumen.

3. The method of claim 2 , wherein extruding comprises manually actuating an extrusion device configured to induce flow of the flowable material out the distal opening of the elongate introducer.

4. The method of claim 1 , wherein the insulative layer comprises a base polymer and a dispersed nonconductive filler.

5. The method of claim 4 , wherein the nonconductive filler comprises hollow microspheres.

6. The method of claim 4 , wherein the base polymer comprises a bio-absorbable material.

7. The method of claim 5 , wherein the hollow microspheres comprise a ceramic or glass.

8. The method of claim 4 , wherein the base polymer is selected from the group consisting of: polyamide, polycarbonate, polystyrene, polyacrylonitrile, polyacetal, thermoplastic modified cellulose, polysulfone, thermoplastic polyester, PET, poly(ethyl acrylate), poly(methyl methacrylate), nylon, fluoropolymer, polyvinylidene fluoride, and ethylene tetrafluoroethylene.

9. The method of claim 1 , wherein the insulative layer has a thermal conductivity of less than about 5 W/m-K.

10. The method of claim 1 , wherein the insulative layer comprises a thermochromic material.

Assignments (1)
SECURITY INTEREST Recorded Jul 30, 2018
From: DFINE, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 046503/0088 →